| Ytd | -41.53% | |
| 1y | -44.50% |
| Open | 4.09 | Prev Close | 4.11 | Low | 4.09 | High | 4.15 | Mkt Cap | 287.29M |
| Vol | 62.04K | Avg Vol | 421.31K | EPS | -2.73 | P/E | -1.52 | Forward P/E | -3.09 |
| Beta | 1.55 | Short Ratio | 14.44 | Inst. Own | 92.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 4.14 | 200-d Avg | 5.48 | 1yr Est | 29.55 |
BCYC News
Visa is set to acquire Israel-based fraud intelligence company BioCatch for $2.4 billion. The all-ca
Needham analyst Ami Fadia maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and lowers the
Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.72) per share which missed the a
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
The mean of analysts' price targets for Bicycle Therapeutics (BCYC) points to a 137.9% upside in the
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ: BCYC - Get Free Report) CEO Kevin Lee sold 5,967 sha
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ: BCYC - Get Free Report) has received a consensus rat
Bicycle Therapeutics (BCYC) is technically in oversold territory now, so the heavy selling pressure
Bicycle Therapeutics (BCYC) is technically in oversold territory now, so the heavy selling pressure
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ: BCYC - Get Free Report) has earned an average rating
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ: BCYC - Get Free Report) has received a consensus rec
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceuti
NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ: BCYC - Get Free Report) has received an average reco
Monday's session saw 84 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 351 stocks hit new 52-week lows.
On Friday morning, 126 companies achieved new highs for the year.
Before 10 a.m. ET on Tuesday, 128 companies hit new 52-week highs.
During the morning session on Friday, 178 stocks hit new 52-week highs.
Before 10 a.m. ET on Wednesday, 375 companies hit new 52-week highs.
Tuesday's morning session saw 269 companies set new 52-week highs.
This morning 150 companies reached new 52-week highs.
Tuesday's morning session saw 195 companies set new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday